Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 69.84% institutional investors, 2.98% insiders, and 27.18% retail investors. Blackrock is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals69.84%2.98%27.18%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%
IdeaCannabis Stocks List12.72%10.49%76.79%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.15M9.83%$655.94M
Vanguard group5.92M9.75%$1.01B
Blackrock funding, inc. /de5.45M8.98%$926.71M
Capital world investors2.67M4.39%$453.32M
Dimensional fund advisors lp2.62M4.32%$445.96M
Lsv asset management2.46M4.05%$417.51M
State street1.87M3.05%$246.19M
Ameriprise financial1.85M3.02%$243.49B
Franklin resources1.82M3.00%$309.21M
Ecor1 capital1.71M2.79%$224.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital1.71M10.79%$224.91M
Krensavage asset management167.82K9.42%$22.12M
Saturn v capital management300.61K8.69%$39.62M
Estuary capital management lp363.15K8.50%$47.86M
Polaris capital management432.47K6.10%$73.52M
Superstring capital management lp40.89K5.31%$5.39M
Gmt capital792.80K4.74%$104.49M
Sofinnova investments588.83K4.24%$77.61M
Acuta capital partners25.11K3.42%$3.31M
Vestal point capital, lp500.00K2.98%$65.90M

Top Buyers

HolderShares% AssetsChange
Franklin resources1.82M0.08%1.13M
Bank of new york mellon1.16M0.04%715.36K
Schonfeld strategic advisors436.44K0.33%373.38K
Allianz asset management gmbh598.83K0.10%242.89K
Woodline partners lp264.97K0.16%232.28K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Blackrock6.15M0.01%-924.16K
Jpmorgan chase1.04M0.01%-822.52K
Vestal point capital, lp500.00K2.98%-700.00K

New Positions

HolderShares% AssetsChangeValue
Walleye capital82.79K0.04%82.79K$10.91M
Centre asset management75.80K2.14%75.80K$9.34M
Simplify asset management71.18K0.20%71.18K$12.10M
Axa investment managers59.87K0.02%59.87K$7.89M
Ing groep nv52.20K0.05%52.20K$8.87M

Sold Out

HolderChange
Psi advisors-1.00
Whittier trust co of nevada-1.00
Thurston, springer, miller, herd & titak-1.00
Center for financial planning-1.00
Kiker wealth management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025394-23.79%42,392,171-30.10%690.71%191-15.49%134-31.98%
Sep 30, 2025488-2.59%58,731,791-0.37%951.03%208-15.10%1876.86%
Jun 30, 2025498-10.75%61,731,8556.44%1001.12%243-23.10%17512.18%
Mar 31, 20255528.02%58,706,955-0.60%961.04%31219.54%155-7.74%
Dec 31, 2024468-2.50%56,158,556-2.64%911.04%238-155-1.27%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
American Funds Fundamental Invs A2.10M3.41%100.00K
Capital Group Fundamental Invtrs Comp2.10M3.41%100.00K
iShares Core S&P Mid-Cap ETF1.96M3.19%-36.87K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Total Stock Mkt Idx Inv1.82M2.96%4.27K
FullerThaler Behavioral Small-Cap Equity1.55M2.52%-
FullerThaler Behavioral Sm-Cp Eq R61.55M2.52%-
Vanguard Small Cap Index1.31M2.12%-264.00
JPM US Mid Cap Value-MA872.29K1.44%16.45K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 09, 2026Carr Patricia SVP, Chief Accounting OfficerSell$235.44K
Mar 03, 2026COZADD BRUCE C-Sell$43.77K
Mar 03, 2026COZADD BRUCE C-Sell$487.00K
Mar 03, 2026COZADD BRUCE C-Sell$587.84K
Feb 27, 2026RIEDEL NORBERT G-Sell$655.68K

Insider Transactions Trends


DateBuySell
2026 Q1-19
2025 Q4-18
2025 Q3-5
2025 Q245
2025 Q1-10

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 69.84%, followed by 2.98% insiders and 27.18% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Jazz Pharmaceuticals falls below.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Blackrock (6.15M shares, 9.83%), Vanguard group (5.92M shares, 9.75%), and Blackrock funding, inc. /de (5.45M shares, 8.98%). Together, they hold 28.56% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.79% of its assets in 1.71M Jazz Pharmaceuticals shares, valued at 224.91M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools